IP Ingredients: The IP in Personalised nutrition

Published mars 2026

IP Ingredients: The IP in Personalised nutrition

Personalised nutrition is the provision of dietary advice which is tailored to a person based on their individual characteristics and lifestyle.  As analytical techniques become faster and cheaper, and AI tools more advanced, businesses are seeking to capitalize on heightened consumer awareness of the impact of diet on health as well as their desire for a personalized approach.

Many companies rely on genetic testing, such as UK-based BioSynergy, which offers personalized dietary advice based on DNA analysis.  Hong Kong start-up GUTolution sequences the gut microbiome to provide diet recommendations, while US-based company Levels provides personalized advice based on blood glucose levels and biomarkers which assess metabolic health.

Other companies circumvent biological testing altogether, relying entirely on an AI-based approach which tailors advice to users’ reported diets.  One such platform is the Birdie app, which takes a user’s answers to dietary questions then searches the scientific literature and medical resources to provide tailored nutritional advice.

There is vast growth potential for businesses operating in the rapidly expanding personalized nutrition sector.  However, to succeed, companies will need to convince consumers that they can deliver substantially more than just standard nutritional advice, and protect their IP to ensure a competitive advantage.

Challenges in patenting personalized nutrition

Generally, technological innovations are protected using patents, and the personalized nutrition field is no exception.  However, as with personalized medicine, there are certain challenges to obtaining patents in this field.  For example, European law prohibits the patenting of therapeutic and diagnostic methods practiced on the body.  In the US, methods which are solely based on a natural phenomenon, such as an increase in a particular biomarker in response to food, are also not eligible for patent protection.  Therefore, patent applications for methods which involve testing patient samples to determine nutritional or metabolic health, or administering certain foods to improve health, must be drafted with these exclusions in mind.

Another challenge is establishing that a method of delivering personalized nutritional advice is novel and non-obvious over what is already known in the field.  In order to provide commercially useful protection, patent claims are often intentionally “broad” or generic.  This may also be necessary to capture the way a method is applied across a whole population.  However, this can seem at odds with the concept of providing nutritional advice which is specific to the individual.

Patenting computer-implemented methods

A common way to protect personalized nutrition, which overcomes some of the above patent eligibility challenges, is to claim a computer-implemented method and a system for carrying out the method.  Such methods typically include steps such as providing test data (e.g. from glucose monitoring or sequencing), using the data to generate a score, and outputting the score, or guidance based on the score, to a user.

In order to pass the inventive step hurdle, the claimed method must go beyond delivering standard dietary advice which is known to be linked to certain physiological states, such as lowering fat consumption to counter high cholesterol.  Experimental data, for example data showing a previously-unknown link between diet and a physiological effect, can help to overcome this hurdle.

Case study

One example of a successful method patent in this field is European patent EP4203712B1 owned by Nestlé.  The patent claims a computer-based method for providing a personalised fibre recommendation based on an individual’s carbohydrate-active enzyme (“CAZyme”) profile.  Based on sequence analysis of faecal samples from 60 subjects, together with the subjects’ answers to a food questionnaire, a machine learning algorithm was developed to determine the likelihood of an individual having a specific CAZyme profile based on the questionnaire alone, thereby enabling the profile of subsequent subjects to be predicted without sampling.  The novelty and inventiveness in the methodology, therefore, lies in the relationship identified between a subject’s food intake and their enzyme profile.

What this shows is that reasonably broad method claims can be obtained in this field when they are based on data which identifies a previously-unknown correlation between food and a particular characteristic.

Composition patents

Companies can also seek composition patents as part of their IP strategy.  Claims to new compositions or other products are often considered desirable since it is generally easier to detect infringement of competitor products than methods.

Companies pursuing claims to new food compositions include ZOE Ltd, which is seeking patent protection for its “Daily30+” plant-based supplement (European patent application EP4585050), and Myota GmbH, which has filed a family of patent applications (based on international application WO2024/115691) directed to a dietary fibre composition.

Food compositions, while not subject to the patent eligibility hurdles that methods are, face an inventive step challenge in that a combination of known ingredients for their known functions is likely to be considered obvious.  Indeed, such objections have been raised against ZOE’s and Myota’s applications by the European Patent Office.  Applicants who can demonstrate, ideally with comparative data, that their formulation provides an unexpected benefit over existing products are therefore more likely to succeed in reaching grant.

Top take-aways for personalized nutrition companies

Personalized nutrition is a complex field encompassing genetics, microbiology, biochemistry, nutrition, formulation chemistry and AI.  The IP issues involved are equally complex, requiring a strategy that is tailored to the company just as its products or services are tailored to the individual.   Things to consider include:

  • Ensuring that patent claims are carefully drafted with the patentability exclusions of key markets in mind. Consider directing claims to computer-implemented methods to avoid some of these exclusions;
  • Generating experimental data to support new methods and compositions prior to filing. For more on data in IP, see our earlier post here;
  • Taking steps to protect unregistered IP that may reside in databases, AI algorithms, and proprietary software, for example by implementing a trade secrets policy, as discussed further here;
  • Using registered trade marks to protect branding; this may be especially important for companies who are not carrying out original research.

 


This article was written by Partner and Patent Attorney Jennifer Bailey

Dernières Actus

Event - 12th Octobre 2026

HGF to attend Festival of Biologics 2026

HGF is pleased to announce that Frédéric Didelon, Partner and European Patent Attorney in our Life Sciences team, will be attending the Festival of Biologics, taking place 13-15 October 2026 …

Détails de l'événement
Event - 29th octobre 2026

Join us for HGF’s IP clinic after ETZ EnergyWorks' Brewed for Growth event

Following ETZ EnergyWorks’ Brewed for Growth event on Thursday 29 October, we are hosting our next IP clinic from 10am-1pm, offering practical, confidential advice at no cost. If you’re developing …

Détails de l'événement
Event - 27th octobre 2026

HGF sponsors pro-manchester Retail Lunch 2026

HGF is delighted to be sponsoring pro-manchester Retail Lunch 2026, taking place on Tuesday 27 October 2026 at INNSiDE by Meliá in Manchester. As part of the event, HGF Partner …

Détails de l'événement
Event - 7th - 10th octobre 2026

HGF Attending AIPPI World Congress 2026

HGF is attending the AIPPI World Congress 2026, taking place in Hamburg from 7-10 October 2026. Bringing together intellectual property professionals from around the world, the annual Congress is one …

Détails de l'événement
Event - 12th novembre 2026

HGF to Host Bionow Biotech & Beers Networking Event in Leeds

HGF is pleased to be partnering with Bionow to host the next Biotech & Beers networking event in Leeds on 12 November 2026, bringing together professionals from across the life …

Détails de l'événement
Event - 18th novembre 2026

HGF Venture: Funding the Future

Join fellow life sciences founders, investors and business leaders for an evening of drinks and networking in Cambridge on the 18th November, 5-9pm. Featuring an investor-founder round table and an …

Détails de l'événement
Event - 22nd septembre 2026

HGF are sponsors of LSPN Europe 2026

HGF is proud to sponsor LSPN Europe 2026, the premier event for IP professionals in the life sciences sector. Join us on September 22-23 in Basel for two days packed …

Détails de l'événement
Event - 2nd septembre 2026

IP Clinic for SMEs at ETZ EnergyWorks

If you’re developing a new technology or growing your business, understanding your intellectual property (IP) early can help you protect your innovation, attract investment and avoid costly mistakes. Join HGF …

Détails de l'événement